Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
Mahesh N Samtani,1 John J Sheehan,2 Dong-Jing Fu,2 Bart Remmerie,3 Jennifer Kern Sliwa,2 Larry Alphs21Janssen Research and Development, Raritan, NJ, USA; 2Janssen Scientific Affairs, Titusville, NJ, USA; 3Janssen Research and Development, Division of Janssen Pharmaceutica, Beerse, BelgiumBackground:...
Guardado en:
Autores principales: | Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db918d18b2894760b2d241167c1b2d3b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Erratum
por: Samtani MN, et al.
Publicado: (2012) -
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
por: Nanda K, et al.
Publicado: (2012) -
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]
por: Nanda K, et al.
Publicado: (2013) -
ModVizPop: A shiny interface for empowering teams to perform interactive pharmacokinetic/pharmacodynamic simulations
por: Pavan Vaddady, et al.
Publicado: (2021) -
Arginine deprivation therapy for malignant melanoma
por: Yoon JK, et al.
Publicado: (2012)